X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs STRIDES PHARMA SCIENCE - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

STRIDES PHARMA SCIENCE 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE STRIDES PHARMA SCIENCE CADILA HEALTHCARE/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 12.7 19.6 64.9% View Chart
P/BV x 2.7 0.8 316.5% View Chart
Dividend Yield % 1.5 0.6 266.4%  

Financials

 CADILA HEALTHCARE   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
STRIDES PHARMA SCIENCE
Mar-18
CADILA HEALTHCARE/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs5581,147 48.6%   
Low Rs362642 56.3%   
Sales per share (Unadj.) Rs116.3317.2 36.7%  
Earnings per share (Unadj.) Rs17.97.8 227.8%  
Cash flow per share (Unadj.) Rs23.125.1 92.3%  
Dividends per share (Unadj.) Rs3.502.00 175.0%  
Dividend yield (eoy) %0.80.2 340.5%  
Book value per share (Unadj.) Rs85.4274.3 31.1%  
Shares outstanding (eoy) m1,023.7489.50 1,143.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.02.8 140.2%   
Avg P/E ratio x25.7114.0 22.6%  
P/CF ratio (eoy) x19.935.7 55.7%  
Price / Book Value ratio x5.43.3 165.0%  
Dividend payout %19.625.5 76.8%   
Avg Mkt Cap Rs m470,66480,058 587.9%   
No. of employees `00011.82.5 471.4%   
Total wages/salary Rs m18,5454,341 427.3%   
Avg. sales/employee Rs Th10,072.711,325.8 88.9%   
Avg. wages/employee Rs Th1,569.11,731.4 90.6%   
Avg. net profit/employee Rs Th1,547.7280.1 552.6%   
INCOME DATA
Net Sales Rs m119,04928,394 419.3%  
Other income Rs m1,132941 120.3%   
Total revenues Rs m120,18129,334 409.7%   
Gross profit Rs m28,4753,965 718.1%  
Depreciation Rs m5,3881,540 349.8%   
Interest Rs m9111,962 46.4%   
Profit before tax Rs m23,3081,403 1,661.1%   
Minority Interest Rs m6280-   
Prior Period Items Rs m0-168 0.0%   
Extraordinary Inc (Exp) Rs m0-436 0.0%   
Tax Rs m5,64497 5,800.6%   
Profit after tax Rs m18,292702 2,605.3%  
Gross profit margin %23.914.0 171.3%  
Effective tax rate %24.26.9 349.2%   
Net profit margin %15.42.5 621.4%  
BALANCE SHEET DATA
Current assets Rs m82,00524,836 330.2%   
Current liabilities Rs m60,72018,993 319.7%   
Net working cap to sales %17.920.6 86.9%  
Current ratio x1.41.3 103.3%  
Inventory Days Days7371 103.1%  
Debtors Days Days98113 86.7%  
Net fixed assets Rs m83,70334,289 244.1%   
Share capital Rs m1,024895 114.4%   
"Free" reserves Rs m86,42123,651 365.4%   
Net worth Rs m87,44524,546 356.3%   
Long term debt Rs m25,55115,513 164.7%   
Total assets Rs m180,65365,437 276.1%  
Interest coverage x26.61.7 1,550.1%   
Debt to equity ratio x0.30.6 46.2%  
Sales to assets ratio x0.70.4 151.9%   
Return on assets %10.64.1 261.1%  
Return on equity %20.92.9 731.3%  
Return on capital %22.06.9 318.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42,68315,697 271.9%   
Fx outflow Rs m11,242735 1,528.7%   
Net fx Rs m31,44114,962 210.1%   
CASH FLOW
From Operations Rs m9,1931,871 491.4%  
From Investments Rs m-9,7375,826 -167.1%  
From Financial Activity Rs m515-10,157 -5.1%  
Net Cashflow Rs m-29-2,615 1.1%  

Share Holding

Indian Promoters % 74.8 27.7 270.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 37.8 22.0%  
FIIs % 5.9 8.6 68.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 25.9 42.5%  
Shareholders   44,069 56,241 78.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   TORRENT PHARMA  ALKEM LABORATORIES  AJANTA PHARMA  SANOFI INDIA  ALEMBIC PHARMA  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 316 m (down 27.5% YoY). Sales on the other hand came in at Rs 8 bn (up 6.1% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jul 19, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - PIRAMAL ENTERPRISES COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS